相似文献
1
Lipoprotein (a) Levels in Relation to Severity of Coronary Artery Disease in North Indian Patients.北印度患者中脂蛋白(a)水平与冠状动脉疾病严重程度的关系
Heart Views. 2013 Jan;14(1):12-6. doi: 10.4103/1995-705X.107114.
2
Lipoprotein(a) and SYNTAX Score Association with Severity of Coronary Artery Atherosclerosis in North India.脂蛋白(a)和SYNTAX评分与印度北部冠状动脉粥样硬化严重程度的关联
Sultan Qaboos Univ Med J. 2012 Nov;12(4):465-72. doi: 10.12816/0003172. Epub 2012 Nov 20.
3
Relook at lipoprotein (A): independent risk factor of coronary artery disease in north Indian population.重新审视脂蛋白（A）：印度北部人群冠状动脉疾病的独立危险因素
Indian Heart J. 2014 May-Jun;66(3):272-9. doi: 10.1016/j.ihj.2014.03.002. Epub 2014 Apr 21.
4
5
Lipoprotein(a) Is Associated with the Presence and Severity of New-Onset Coronary Artery Disease in Postmenopausal Women.脂蛋白(a)与绝经后女性新发冠状动脉疾病的发生和严重程度相关。
J Womens Health (Larchmt). 2020 Apr;29(4):503-510. doi: 10.1089/jwh.2019.7773. Epub 2020 Jan 6.
6
Elevated lipoprotein (a) levels are associated with the presence and severity of coronary artery disease in patients with type 2 diabetes mellitus.在2型糖尿病患者中，脂蛋白（a）水平升高与冠状动脉疾病的存在及严重程度相关。
Nutr Metab Cardiovasc Dis. 2018 Oct;28(10):980-986. doi: 10.1016/j.numecd.2018.05.010. Epub 2018 May 28.
7
Correlation of lipoprotein (a) to angiographically defined coronary artery disease in Indians.印度人群中脂蛋白（a）与血管造影定义的冠状动脉疾病的相关性。
Int J Cardiol. 1996 Dec 13;57(3):265-70. doi: 10.1016/s0167-5273(96)02800-8.
8
Triglyceride and lipoprotein (a) are markers of coronary artery disease severity among postmenopausal women.甘油三酯和脂蛋白(a)是绝经后女性冠状动脉疾病严重程度的标志物。
Maturitas. 2001 Sep 28;39(3):203-8. doi: 10.1016/s0378-5122(01)00223-7.
9
Lipoprotein(a) and lipid profiles of patients awaiting coronary artery bypass graft; a cross sectional study.等待冠状动脉搭桥手术患者的脂蛋白(a)和血脂谱；一项横断面研究。
BMC Cardiovasc Disord. 2016 Nov 8;16(1):213. doi: 10.1186/s12872-016-0393-1.
10
Lipoprotein(a) and coronary artery disease in Chinese postmenopausal female patients: a large cross-sectional cohort study.载脂蛋白(a)与中国绝经后女性冠心病的相关性：一项大型横断面队列研究。
Postgrad Med J. 2019 Oct;95(1128):534-540. doi: 10.1136/postgradmedj-2019-136591. Epub 2019 Jul 17.
引用本文的文献
1
Cross-sectional study of lipoprotein(a) and the severity of coronary artery disease, cerebrovascular disease, and peripheral vascular disease in a group of South Asian patients.一项针对一组南亚患者的脂蛋白(a)与冠状动脉疾病、脑血管疾病及外周血管疾病严重程度的横断面研究。
Cardiovasc Endocrinol Metab. 2025 Mar 27;14(2):e00327. doi: 10.1097/XCE.0000000000000327. eCollection 2025 Jun.
2
Association of lipoprotein (a) with coronary artery disease in a South Asian population: A case-control study.载脂蛋白(a)与南亚人群冠心病的相关性：一项病例对照研究。
PLoS One. 2022 May 3;17(5):e0267807. doi: 10.1371/journal.pone.0267807. eCollection 2022.
3
Lipoprotein(a): An underrecognized genetic risk factor for malignant coronary artery disease in young Indians.脂蛋白(a)：印度年轻人群中未被充分认识的恶性冠状动脉疾病遗传危险因素。
Indian Heart J. 2019 May-Jun;71(3):184-198. doi: 10.1016/j.ihj.2019.04.007. Epub 2019 May 2.
4
Adaptation of 2016 European Society of Cardiology/European Atherosclerosis Society guideline for lipid management to Indian patients - A consensus document.《2016年欧洲心脏病学会/欧洲动脉粥样硬化学会血脂管理指南对印度患者的适用性——一份共识文件》
Indian Heart J. 2018 Sep-Oct;70(5):736-744. doi: 10.1016/j.ihj.2018.03.011. Epub 2018 Jul 18.
5
South Asian Cardiovascular Disease & Cancer Risk: Genetics & Pathophysiology.南亚心血管疾病和癌症风险：遗传学和病理生理学。
J Community Health. 2018 Dec;43(6):1100-1114. doi: 10.1007/s10900-018-0527-8.
6
PCSK9 in chronic kidney disease.慢性肾脏病中的前蛋白转化酶枯草溶菌素9
Int Urol Nephrol. 2017 Jun;49(6):1015-1024. doi: 10.1007/s11255-017-1505-2. Epub 2017 Jan 13.
7
Association of a methylene tetrahydrofolate reductase C677T polymorphism with several blood chemical levels in a Chinese population.中国人群中亚甲基四氢叶酸还原酶C677T多态性与多种血液化学指标的关联
Genet Test Mol Biomarkers. 2015 Jan;19(1):24-9. doi: 10.1089/gtmb.2014.0213.
8
Relook at lipoprotein (A): independent risk factor of coronary artery disease in north Indian population.重新审视脂蛋白（A）：印度北部人群冠状动脉疾病的独立危险因素
Indian Heart J. 2014 May-Jun;66(3):272-9. doi: 10.1016/j.ihj.2014.03.002. Epub 2014 Apr 21.
本文引用的文献
1
The role of hypertriglyceridemia in atherosclerosis.高甘油三酯血症在动脉粥样硬化中的作用。
Curr Atheroscler Rep. 2007 Aug;9(2):110-5. doi: 10.1007/s11883-007-0006-7.
2
Lipoprotein retention--and clues for atheroma regression.脂蛋白潴留——以及动脉粥样硬化消退的线索。
Arterioscler Thromb Vasc Biol. 2005 Aug;25(8):1536-40. doi: 10.1161/01.ATV.0000174795.62387.d3.
3
Lipoprotein(a) and the link between atherosclerosis and thrombosis.脂蛋白(a)以及动脉粥样硬化与血栓形成之间的联系。
Can J Cardiol. 2004 Aug;20 Suppl B:37B-43B.
4
Use of metabolic markers to identify overweight individuals who are insulin resistant.使用代谢标志物来识别胰岛素抵抗的超重个体。
Ann Intern Med. 2003 Nov 18;139(10):802-9. doi: 10.7326/0003-4819-139-10-200311180-00007.
5
Insulin resistance/compensatory hyperinsulinemia, essential hypertension, and cardiovascular disease.胰岛素抵抗/代偿性高胰岛素血症、原发性高血压和心血管疾病。
J Clin Endocrinol Metab. 2003 Jun;88(6):2399-403. doi: 10.1210/jc.2003-030087.
6
Diabetic dyslipidaemia: from basic research to clinical practice.糖尿病血脂异常：从基础研究到临床实践
Diabetologia. 2003 Jun;46(6):733-49. doi: 10.1007/s00125-003-1111-y. Epub 2003 May 28.
7
Lipoprotein (a) as a predictor of coronary heart disease: the PRIME Study.脂蛋白（a）作为冠心病的预测指标：PRIME研究
Atherosclerosis. 2002 Aug;163(2):377-84. doi: 10.1016/s0021-9150(02)00026-6.
8
Lipoprotein (a) binds and inactivates tissue factor pathway inhibitor: a novel link between lipoproteins and thrombosis.脂蛋白（a）结合并使组织因子途径抑制物失活：脂蛋白与血栓形成之间的新联系。
Blood. 2001 Nov 15;98(10):2980-7. doi: 10.1182/blood.v98.10.2980.
9
Lipoprotein(a) further increases the risk of coronary events in men with high global cardiovascular risk.脂蛋白(a)会进一步增加全球心血管风险高的男性发生冠状动脉事件的风险。
J Am Coll Cardiol. 2001 Feb;37(2):434-9. doi: 10.1016/s0735-1097(00)01126-8.
10
Lipoprotein(a) and coronary heart disease. Meta-analysis of prospective studies.脂蛋白（a）与冠心病。前瞻性研究的荟萃分析。
Circulation. 2000 Sep 5;102(10):1082-5. doi: 10.1161/01.cir.102.10.1082.
Zotero 插件